Aripiprazol "Stada" 5 mg tabletter Dánsko - dánčina - Lægemiddelstyrelsen (Danish Medicines Agency)

aripiprazol "stada" 5 mg tabletter

stada arzneimittel ag - aripiprazol - tabletter - 5 mg

Lopid 600 mg filmovertrukne tabletter Dánsko - dánčina - Lægemiddelstyrelsen (Danish Medicines Agency)

lopid 600 mg filmovertrukne tabletter

2care4 aps - gemfibrozil - filmovertrukne tabletter - 600 mg

Lopid 600 mg filmovertrukne tabletter Dánsko - dánčina - Lægemiddelstyrelsen (Danish Medicines Agency)

lopid 600 mg filmovertrukne tabletter

orifarm a/s - gemfibrozil - filmovertrukne tabletter - 600 mg

Lopid 300 mg kapsler, hårde Dánsko - dánčina - Lægemiddelstyrelsen (Danish Medicines Agency)

lopid 300 mg kapsler, hårde

pfizer aps - gemfibrozil - kapsler, hårde - 300 mg

Lopid 300 mg kapsler, h?rde Dánsko - dánčina - Lægemiddelstyrelsen (Danish Medicines Agency)

lopid 300 mg kapsler, h?rde

2care4 aps - gemfibrozil - kapsler, hårde - 300 mg

GHRYVELIN (previously Macimorelin Aeterna Zentaris) Európska únia - dánčina - EMA (European Medicines Agency)

ghryvelin (previously macimorelin aeterna zentaris)

atnahs pharma netherlands b.v. - macimorelin acetat - diagnostiske teknikker, hormonforstyrrende - macimorelin - dette lægemiddel er kun til diagnostisk brug.  ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Lopid 600 mg filmovertrukne tabletter Dánsko - dánčina - Lægemiddelstyrelsen (Danish Medicines Agency)

lopid 600 mg filmovertrukne tabletter

nordic prime aps - gemfibrozil - filmovertrukne tabletter - 600 mg

Lopid 300 mg kapsler, h?rde Dánsko - dánčina - Lægemiddelstyrelsen (Danish Medicines Agency)

lopid 300 mg kapsler, h?rde

orifarm a/s - gemfibrozil - kapsler, hårde - 300 mg

Ayvakyt Európska únia - dánčina - EMA (European Medicines Agency)

ayvakyt

blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinale stromale tumorer - andre antineoplastiske midler, protein kinase hæmmere - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

Orserdu Európska únia - dánčina - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.